Discover the liver cancer therapeutics market's expansion to US$13.16 billion by 2033 with 16.5% CAGR. Key insights on North America's 42.1% share, chemotherapy's 39.1% dominance, and oral administration's 54.1% lead fueled by players like AstraZeneca and Bristol-Myers Squibb. https://finance.yahoo.com/news/liver-cancer-therapeutics-market-size-140100776.html